Patients' perceptions of topical treatments of actinic keratosis

被引:21
|
作者
Esmann, Solveig [1 ]
Jemec, Gregor B. E. [1 ]
机构
[1] Univ Copenhagen, Fac Hlth Sci, Roskilde Hosp, Dept Dermatol, DK-4000 Roskilde, Denmark
关键词
actinic keratosis; topical treatment; efficiency; pain; patient perspectives; interview; TREATMENT SATISFACTION; PHOTODYNAMIC THERAPY; 5-FLUOROURACIL; STIGMATIZATION; DERMATOLOGY; 0.5-PERCENT; EXPERIENCE; MANAGEMENT; PHYSICIANS; ADHERENCE;
D O I
10.3109/09546634.2012.757285
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives: In recent years, a number of topical treatments suitable for field-directed therapy of actinic keratosis (AK) have been developed. Non-surgical treatment of AK however requires strict adherence by patients. Patients' views on the different possible topical treatments are therefore relevant to the choice of treatment. The aim of the study was to disclose the "silent perspectives" by focusing on user experiences and individual perspectives on topical treatment. Materials and methods: Telephone interviews and face-to-face interviews were conducted with patients having had treatment with one or more of the following: imiquimod 5%, diclofenac sodium gel 3%, 5-fluorouracil (5-FU) cream 5% or photodynamic therapy. Results: 24 patients with AK were interviewed. Experiences of pain, discharging ulcers and efficiency of the treatment were of major importance. There was a general focus on appearance, social contacts and leisure time, although this appeared to be of lesser importance. Patients' perception of treatment instructions identified a risk of misunderstandings. Conclusion: Patients are primarily concerned with therapeutic efficiency. Pain and ulcers are central indicators, but appearance, social contacts and leisure time can also be considered as additional indicators of satisfaction. A firm focus on patient instruction is suggested.
引用
收藏
页码:375 / 379
页数:5
相关论文
共 50 条
  • [1] Adherence to topical treatments for actinic keratosis
    Cardwell, L. A.
    Feldman, S. R.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) : 872 - 872
  • [2] An economic evaluation of topical treatments for actinic keratosis
    Muston, Dominic
    Downs, Anthony
    Rives, Vincent
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2009, 20 (05) : 266 - 275
  • [3] Non-adherence to topical treatments for actinic keratosis
    Shergill, Bav
    Zokaie, Simon
    Carr, Alison J.
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 35 - 41
  • [4] Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States
    Tan, Isabella J.
    Pathak, Gaurav N.
    Silver, Frederick H.
    CANCERS, 2023, 15 (15)
  • [5] Exploring Anti-Aging Effects of Topical Treatments for Actinic Keratosis
    Li Pomi, Federica
    d'Aloja, Andrea
    Valguarnera, Dario
    Vaccaro, Mario
    Borgia, Francesco
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [6] No effect of topical digoxin and furosemide for patients with actinic keratosis
    Huisman, Bertine W.
    Nene, Lauren E. H.
    Linders, Feeke L. L.
    Gambrah, Tom K.
    van Der Kolk, Tessa Niemeyer
    de Kam, Marieke L.
    Bavinck, Jan Nico Bouwes
    Burggraaf, Jacobus
    Feiss, Gary
    Rissmann, Robert
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (02) : E172 - E174
  • [7] Topical imiquimod in the treatment of actinic keratosis
    Bianchi, L
    Campione, E
    Carboni, I
    Barbati, R
    Soda, R
    Chimenti, S
    EXPERIMENTAL DERMATOLOGY, 2002, 11 (03) : 276 - 276
  • [8] Tirbanibulin: Topical Treatment for Actinic Keratosis
    Dlott, Anna H.
    Di Pasqua, Anthony J.
    Spencer, Sara A.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (09) : 751 - 755
  • [9] Tirbanibulin: Topical Treatment for Actinic Keratosis
    Anna H. Dlott
    Anthony J. Di Pasqua
    Sara A. Spencer
    Clinical Drug Investigation, 2021, 41 : 751 - 755
  • [10] Topical therapy for actinic keratosis: An update
    Gupta, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 8 - 8